More good news, things are looking great for Clinuvel!
Price has been declining whilst fundamentals have been improving, such irrational behaviour is where opportunities are found (yet for some reason people love to wait to buy till the price has jumped 100% and all the brokers are pumping it).
- Forums
- ASX - By Stock
- CUV
- Ann: afamelanotide in fair-skinned Parkinsons patients
Ann: afamelanotide in fair-skinned Parkinsons patients, page-4
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.63 |
Change
0.120(0.89%) |
Mkt cap ! $682.3M |
Open | High | Low | Value | Volume |
$13.55 | $13.77 | $13.43 | $581.2K | 42.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 248 | $13.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.64 | 1 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 248 | 13.620 |
1 | 156 | 13.560 |
1 | 100 | 13.410 |
2 | 107 | 13.400 |
1 | 100 | 13.390 |
Price($) | Vol. | No. |
---|---|---|
13.770 | 193 | 1 |
13.790 | 193 | 1 |
13.800 | 193 | 1 |
13.820 | 193 | 1 |
13.880 | 800 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online